Education Program Details
Target Audience
The Society supports the entire interdisciplinary team and provides educational activities to be of value to the following post-acute and long-term care (PALTC) professionals:
- Physicians
- Medical Directors
- Nurse Practitioners
- Physician Assistants
- Consultant Pharmacists
- Psychologists
- Practice Managers
However, the educational content is applicable to other members of the interdisciplinary team, including administrators, DONs, nurses, social workers, etc.
Overall Goal
The overall goal of this program is to enhance participants’ knowledge and competencies by providing the latest developments and tools available to improve the delivery of quality care in PALTC medicine.
Learning Objectives
Upon conclusion of participating in this educational activity, attendees should be able to:
- Address the impact of racism and microaggression in the delivery of care in the PALTC environment.
- Analyze available data to improve process and promote quality improvement in PALTC.
- Discuss clinical advances and new research findings relevant to PALTC medicine.
- Enhance skills and abilities to collaborate with and/or lead the PALTC interdisciplinary team.
- Foster creativity and innovation in PALTC.
- Gain new perspectives on relevant aspects of fiscal issues, health care policy, payment models, risk management and the Society’s policy priorities.
- Implement Clinical Practice Guidelines (CPGs) in the PALTC setting.
- Implement strategies for effective communication with patients, families and care teams.
- Implement strategies to identify and address healthcare disparities in PALTC.
- Incorporate and refine skills, attitudes, and knowledge to improve leadership effectiveness within a health care organization or facility.
- Implement sustainable strategies to reduce health disparities, improve health equity and Inclusion among post-acute and long-term care residents.
- Integrate knowledge and skills in assessment and management of ethical challenges and dilemmas in PALTC.
- Integrate knowledge and skills gained to enhance the effectiveness and quality of medical direction in nursing facilities.
- Utilize available data, tools, and emerging technologies to inform decisions about clinical care and/or medical direction.
Learner Assurance Statement and the Society Policy on Disclosure and Resolution of Conflict of Interest
It is the Society’s policy that all those in a position to directly control CME content, such as, planning committees, faculty, and authors, disclose any relationships with commercial entities upon nomination or invitation for participation. Disclosure documents are reviewed in advance for potential conflicts of interest. If conflicts are identified, they are resolved prior to confirmation of participation to ensure participation and/or presentation is non-biased/ promotional, evidence-based and scientifically sound. Only those participants who had no conflict of interest or who agreed to an identified resolution process prior to their participation are involved in this CME activity.
Disclosures of Relevant Financial Relationships
All relationships disclosed by those in control of content have been noted in conference materials. Financial relationships with Ineligible Companies* relevant to the content of the conference are as follows and have been mitigated:
- Ann R. Falsey, MD (Speaker): ADMA Biologics: Board Member (Ongoing), BioFire Diagnostics: Contracted Research, Cyan Vac: Clinical Trial Investigator (Ongoing), GSK: Travel to VRBPAC (Ongoing), Icosavax: Consultant (Ongoing), Janssen Biotech: Contracted Research (Ongoing), Merck: Contracted Research (Ongoing); Moderna: Consultant (Ongoing), Contracted Research (Ongoing), Pfizer: Contracted Research (Ongoing)
- Tom C. Haithcoat (Speaker): CareConnectMD: Advisory Board (Ongoing), Consultant (Ongoing), Employment (Ongoing), Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); Careline Health Group: Consultant (Ongoing)|; Ceptor Consulting, LLC: Board Member (Ongoing), Employment (Ongoing), Stockholder/Ownership Interest (Ongoing); Geriatric Medical Specialist, LLC: Board Member (Ongoing), Employment (Ongoing), Stockholder/Ownership Interest (Ongoing); HealthPivot: Consultant (Ongoing); PointClickCare: Consultant (Ongoing)
- Robin L. Jump, MD, PhD (Speaker): Merck: Contracted Research (Ongoing); Pfizer: Advisory Board (Ongoing), Contracted Research (Ongoing)
- Morgan Katz, MD, MHS (Speaker): HQI Solutions: Consultant (Ongoing)
- Joseph G. Ouslander, MD (Speaker): Pathway Health: Advisory Board (Ongoing); PointClickCare: Contracted Research (Ongoing); The Mayer-Rothchild Foundation: Contracted Research (Ongoing)
- Naushira Pandya, MD, CMD, FACP (Speaker): Lilly: Speaker's Bureau (Ongoing); Sanofi: Advisory Board (Ongoing), Consultant (Ongoing)
- Amita R. Patel, MD, CMD, MHA, CPE (Speaker): Acadia: Speaker's Bureau (Ongoing), Neurocrine: Speaker's Bureau (Ongoing), Otsuka: Speaker's Bureau (Ongoing), Teva: Speaker's Bureau (Ongoing)
- Meenakshi Patel, MD, FACP, MMM, CMD (Speaker): Eli Lilly: Clinical Trial Investigator (Ongoing), Contracted Research (Ongoing); GSK: Clinical Trial Investigator (Ongoing), Contracted Research (Ongoing); Janssen: Speaker's Bureau (Ongoing); Otsuka: Speaker's Bureau (Ongoing); Sumitomo: Speaker's Bureau (Ongoing); Teva: Speaker's Bureau (Ongoing)
- Alexis Ritvo, MD, MPH (Speaker): Alliance for Benzodiazepine Best Practices: contracted as medical director (Ongoing)
- Muhammad Salman Ashraf (Facilitator): Merck & Co. Inc: PI for investigator-initiated research grant
- Elizabeth Sobczyk, MSW, MPH (Speaker): Sanofi Pasteur: Advisory Board, Honorarium
- Todd Sobol, MD, FACP, CMD (Speaker): CareBand: Advisory Board (Ongoing), Board Member (Ongoing), Stockholder/Ownership Interest (Ongoing)
- Jessica Stone, NP, PMHNP (Planner): Acadia: Speaker Bureau
- Gianna R. Strand, MS, DBe (Speaker): Columbia University: Employment; The Completed Life Initiative: Board Member (Ongoing), Employment (Ongoing)
- Kenya Rivas Velasquez, MD, CMD, FAAFP (Planner & Speaker): OptumRx: Stockholder
- Sabine M. von Preyss-Friedman, MD, CMD, FACP (Speaker): Avalon Healthcare: Employment (Ongoing); Caldera Care: Consultant (Ongoing)
- Barbara Zarowitz, PharmD, MSW (Speaker): Akebia: Consultant; Eli Lilly: Consultant; Merck: Consultant
No one else in control of content has any relevant financial relationships with *"companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients."
.png)
.png)